Traditional approaches to sLND have shown limited long-term cancer control: Bravi et al. reported a 10-year cancer-specific survival rate of only 66%, with many patients demonstrating persistently elevated PSA postoperatively, likely due to incomplete resection of metastases and limitations of conventional imaging [68]. This evidence concerns the gene KLK3 and cancer.